Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Operating Expenses (2020 - 2025)

BioAtla (BCAB) has 6 years of Operating Expenses data on record, last reported at $13.8 million in Q3 2025.

  • For Q3 2025, Operating Expenses fell 38.08% year-over-year to $13.8 million; the TTM value through Sep 2025 reached $66.3 million, down 31.82%, while the annual FY2024 figure was $84.9 million, 34.5% down from the prior year.
  • Operating Expenses reached $13.8 million in Q3 2025 per BCAB's latest filing, down from $18.6 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $37.2 million in Q2 2023 and bottomed at $13.8 million in Q3 2025.
  • Average Operating Expenses over 5 years is $24.7 million, with a median of $24.3 million recorded in 2022.
  • Peak YoY movement for Operating Expenses: skyrocketed 1469.03% in 2021, then crashed 43.08% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $23.5 million in 2021, then rose by 21.59% to $28.6 million in 2022, then fell by 0.08% to $28.5 million in 2023, then plummeted by 43.08% to $16.2 million in 2024, then fell by 15.11% to $13.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $13.8 million in Q3 2025, $18.6 million in Q2 2025, and $17.6 million in Q1 2025.